223 related articles for article (PubMed ID: 32674872)
21. Behavioral Determinants of Canadian Radiation Oncologists' Use of Single Fraction Palliative Radiation Therapy for Uncomplicated Bone Metastases.
Squires JE; Asad S; Varin MD; Dorrance K; Chow E; Fairchild A; Wong R; Graham ID; Grimshaw JM; Dennis K
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):374-386. PubMed ID: 32966890
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.
Levy JF; Khairnar R; Louie AV; Showalter TN; Mullins CD; Mishra MV
Pract Radiat Oncol; 2019 Mar; 9(2):e172-e179. PubMed ID: 30342180
[TBL] [Abstract][Full Text] [Related]
23. Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis.
Donovan EK; Sienna J; Mitera G; Kumar-Tyagi N; Parpia S; Swaminath A
Radiother Oncol; 2019 May; 134():55-66. PubMed ID: 31005225
[TBL] [Abstract][Full Text] [Related]
24. Does dissemination of guidelines alone increase the use of palliative single-fraction radiotherapy? Initial report of a longitudinal change management campaign at a provincial cancer program.
Kim JO; Hanumanthappa N; Chung YT; Beck J; Koul R; Bashir B; Cooke A; Dubey A; Butler J; Nashed M; Hunter W; Ong A
Curr Oncol; 2020 Aug; 27(4):190-197. PubMed ID: 32905177
[TBL] [Abstract][Full Text] [Related]
25. Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction versus multiple fraction radiotherapy.
Musio D; De Francesco I; Galdieri A; Marsecano C; Piciocchi A; Napoli A; De Felice F; Tombolini V
Eur J Radiol; 2018 Jan; 98():1-6. PubMed ID: 29279145
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States.
Cho SK; Hay JW; Barzi A
Clin Colorectal Cancer; 2018 Dec; 17(4):e751-e761. PubMed ID: 30228027
[TBL] [Abstract][Full Text] [Related]
28. The Hopeless Case? Palliative Cryoablation and Cementoplasty Procedures for Palliation of Large Pelvic Bone Metastases.
Coupal TM; Pennycooke K; Mallinson PI; Ouellette HA; Clarkson PW; Hawley P; Munk PL
Pain Physician; 2017 Nov; 20(7):E1053-E1061. PubMed ID: 29149150
[TBL] [Abstract][Full Text] [Related]
29. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
Acevedo JR; Fero KE; Wilson B; Sacco AG; Mell LK; Coffey CS; Murphy JD
J Clin Oncol; 2016 Nov; 34(32):3886-3891. PubMed ID: 27551113
[TBL] [Abstract][Full Text] [Related]
31. Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort.
Conway JL; Yurkowski E; Glazier J; Gentles Q; Walter A; Bowering G; Curtis S; Schellenberg D; Halperin R; Lapointe V; Beckham W; Olivotto IA; Olson RA
Radiother Oncol; 2016 May; 119(2):202-7. PubMed ID: 27072939
[TBL] [Abstract][Full Text] [Related]
32. Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States.
Garrison LP; Babigumira J; Tournier C; Goertz HP; Lubinga SJ; Perez EA
Value Health; 2019 Apr; 22(4):408-415. PubMed ID: 30975391
[TBL] [Abstract][Full Text] [Related]
33. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older.
Ward MC; Vicini F; Al-Hilli Z; Chadha M; Pierce L; Recht A; Hayman J; Thaker N; Khan AJ; Keisch M; Shah C
Breast Cancer Res Treat; 2020 Jul; 182(2):355-365. PubMed ID: 32468336
[TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
[TBL] [Abstract][Full Text] [Related]
36. Use of single- versus multiple-fraction palliative radiation therapy for bone metastases: population-based analysis of 16,898 courses in a Canadian province.
Olson RA; Tiwana MS; Barnes M; Kiraly A; Beecham K; Miller S; Hoegler D; Olivotto I
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1092-1099. PubMed ID: 25035213
[TBL] [Abstract][Full Text] [Related]
37. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
38. Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma.
Fust K; Li X; Maschio M; Villa G; Parthan A; Barron R; Weinstein MC; Somers L; Hoefkens C; Lyman GH
Pharmacoeconomics; 2017 Apr; 35(4):425-438. PubMed ID: 27928760
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation.
Reynolds MR; Lamotte M; Todd D; Khaykin Y; Eggington S; Tsintzos S; Klein G
Europace; 2014 May; 16(5):652-9. PubMed ID: 24390386
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
